Skip to content

EBITDA at other companies

HRO
HarrowHROW
-$21.63M-101%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$655M-213%
Procter & Gamble logo
Procter & GamblePG
Johnson & Johnson logo
Johnson & JohnsonJNJ
Cencora logo
CencoraCOR
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Prestige Consumer Healthcare’s reported figures.

$75.5Mebit+
$8.4MDepreciation Depletion & Amortization
=$83.84M

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's EBITDA?
Prestige Consumer Healthcare (PBH) reported EBITDA of $83.84M in Q1 2026.
How has Prestige Consumer Healthcare's EBITDA changed year-over-year?
Prestige Consumer Healthcare's EBITDA decreased by 12.4% year-over-year, from $95.68M to $83.84M.
What is the long-term trend for Prestige Consumer Healthcare's EBITDA?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's EBITDA has grown at a -1.5% compound annual growth rate (CAGR), from $362.01M to $340.68M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.